Tag: ACIP

ACIP meeting, Casey Means, forever chemicals: Morning Rounds

Looksmaxxing Trend and Its Impact The concept of "looksmaxxing" has recently gained attention within STAT's science team meetings.

Nicotine, SSRIs, ACIP, NIH, caffeine: Morning Rounds

Nicotine gets a makeover, courtesy of biohackers and influencers With smoking rates on the decline in the U.S.,

ACIP panel may postpone meeting, latest sign of CDC dysfunction

The Department of Health and Human Services has failed to meet the legal deadline to announce an upcoming

RFK Jr. adds OB-GYNs to ACIP amid review of shots during pregnancy

Health secretary Robert F. Kennedy Jr. has made significant changes to the main federal vaccine advisory board by

Childhood vaccines facing scrutiny by Kennedy’s ACIP panel

The recent decision by the Advisory Committee on Immunization Practices (ACIP) to recommend a major change to childhood

Vaccine critic Aaron Siri presents at ACIP meeting

The discussion surrounding the future of children's vaccines took center stage at today's meeting of federal vaccine advisers,

RFK Jr.’s ACIP panel recommends delay in newborn hepatitis B vaccination

The Advisory Committee on Immunization Practices, a panel that advises on U.S. vaccine policy, made a significant decision

HPV shot, Marburg vaccine, ACIP hep b: Morning Rounds

The CDC vaccine advisory committee meeting kicked off with a bang as discussions around hepatitis B vaccinations for

Tracy Beth Høeg, Vinay Prasad, ACIP, FDA: Morning Rounds

The FDA has announced that Tracy Beth Høeg will be taking over as the new leader of the

ACIP hepatitis B review: Vaccine experts say they’re being excluded

The federal government's vaccine advisory panel is set to evaluate the hepatitis B vaccine this week, but there

ACIP staff, Ebola outbreak, Marion Nestle: Morning Rounds

The recent shakeup at the CDC’s Advisory Committee on Immunization Practices (ACIP) has raised eyebrows and concerns within

ACIP hep b vaccine, FDA drug vouchers: Morning Rounds

The Trump administration recently announced a groundbreaking deal that aims to make popular anti-obesity drugs more affordable for